ＪＣＲファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/03/13 | 1,487 | 1,515 | 1,481 | 1,505 | -22 | -1.4% | 261,100 |
| 2023/03/10 | 1,582 | 1,589 | 1,527 | 1,527 | -79 | -4.9% | 496,600 |
| 2023/03/09 | 1,550 | 1,652 | 1,547 | 1,606 | +89 | +5.9% | 957,900 |
| 2023/03/08 | 1,492 | 1,525 | 1,486 | 1,517 | +33 | +2.2% | 428,500 |
| 2023/03/07 | 1,487 | 1,502 | 1,475 | 1,484 | +5 | +0.3% | 345,500 |
| 2023/03/06 | 1,477 | 1,488 | 1,466 | 1,479 | -6 | -0.4% | 351,000 |
| 2023/03/03 | 1,460 | 1,488 | 1,445 | 1,485 | +37 | +2.6% | 416,700 |
| 2023/03/02 | 1,413 | 1,448 | 1,405 | 1,448 | +25 | +1.8% | 422,600 |
| 2023/03/01 | 1,470 | 1,473 | 1,404 | 1,423 | -45 | -3.1% | 560,100 |
| 2023/02/28 | 1,475 | 1,483 | 1,445 | 1,468 | +19 | +1.3% | 419,400 |
| 2023/02/27 | 1,459 | 1,465 | 1,433 | 1,449 | -36 | -2.4% | 390,400 |
| 2023/02/24 | 1,509 | 1,516 | 1,455 | 1,485 | -25 | -1.7% | 420,500 |
| 2023/02/22 | 1,512 | 1,523 | 1,487 | 1,510 | -21 | -1.4% | 440,600 |
| 2023/02/21 | 1,557 | 1,559 | 1,523 | 1,531 | -26 | -1.7% | 239,300 |
| 2023/02/20 | 1,557 | 1,574 | 1,530 | 1,557 | ±0 | ±0% | 269,800 |
| 2023/02/17 | 1,581 | 1,587 | 1,553 | 1,557 | -42 | -2.6% | 277,700 |
| 2023/02/16 | 1,610 | 1,617 | 1,582 | 1,599 | +2 | +0.1% | 279,700 |
| 2023/02/15 | 1,620 | 1,620 | 1,583 | 1,597 | -15 | -0.9% | 224,400 |
| 2023/02/14 | 1,620 | 1,628 | 1,585 | 1,612 | +14 | +0.9% | 238,000 |
| 2023/02/13 | 1,615 | 1,615 | 1,583 | 1,598 | -43 | -2.6% | 305,900 |
| 2023/02/10 | 1,628 | 1,642 | 1,612 | 1,641 | -16 | -1% | 318,200 |
| 2023/02/09 | 1,646 | 1,660 | 1,617 | 1,657 | -18 | -1.1% | 416,300 |
| 2023/02/08 | 1,711 | 1,715 | 1,659 | 1,675 | -5 | -0.3% | 297,300 |
| 2023/02/07 | 1,735 | 1,735 | 1,659 | 1,680 | -61 | -3.5% | 590,800 |
| 2023/02/06 | 1,678 | 1,748 | 1,659 | 1,741 | +143 | +8.9% | 958,000 |
| 2023/02/03 | 1,653 | 1,654 | 1,587 | 1,598 | -47 | -2.9% | 307,600 |
| 2023/02/02 | 1,648 | 1,664 | 1,627 | 1,645 | +9 | +0.6% | 393,400 |
| 2023/02/01 | 1,635 | 1,680 | 1,615 | 1,636 | +41 | +2.6% | 552,100 |
| 2023/01/31 | 1,593 | 1,615 | 1,586 | 1,595 | -15 | -0.9% | 381,500 |
| 2023/01/30 | 1,624 | 1,628 | 1,597 | 1,610 | -22 | -1.3% | 309,100 |
| 2023/01/27 | 1,675 | 1,677 | 1,626 | 1,632 | -43 | -2.6% | 303,600 |
| 2023/01/26 | 1,674 | 1,691 | 1,665 | 1,675 | -12 | -0.7% | 298,500 |
| 2023/01/25 | 1,689 | 1,699 | 1,661 | 1,687 | -12 | -0.7% | 473,700 |
| 2023/01/24 | 1,647 | 1,730 | 1,634 | 1,699 | +91 | +5.7% | 789,800 |
| 2023/01/23 | 1,583 | 1,610 | 1,571 | 1,608 | +58 | +3.7% | 456,300 |
| 2023/01/20 | 1,544 | 1,553 | 1,526 | 1,550 | +5 | +0.3% | 247,500 |
| 2023/01/19 | 1,530 | 1,558 | 1,516 | 1,545 | -2 | -0.1% | 223,100 |
| 2023/01/18 | 1,495 | 1,550 | 1,495 | 1,547 | +64 | +4.3% | 295,300 |
| 2023/01/17 | 1,494 | 1,502 | 1,478 | 1,483 | -20 | -1.3% | 198,000 |
| 2023/01/16 | 1,488 | 1,513 | 1,487 | 1,503 | -5 | -0.3% | 188,800 |
| 2023/01/13 | 1,527 | 1,540 | 1,494 | 1,508 | -32 | -2.1% | 292,100 |
| 2023/01/12 | 1,557 | 1,587 | 1,524 | 1,540 | +5 | +0.3% | 274,000 |
| 2023/01/11 | 1,502 | 1,558 | 1,500 | 1,535 | +42 | +2.8% | 392,800 |
| 2023/01/10 | 1,550 | 1,569 | 1,486 | 1,493 | -51 | -3.3% | 382,300 |
| 2023/01/06 | 1,521 | 1,554 | 1,521 | 1,544 | +14 | +0.9% | 364,800 |
| 2023/01/05 | 1,580 | 1,582 | 1,527 | 1,530 | -54 | -3.4% | 375,200 |
| 2023/01/04 | 1,676 | 1,676 | 1,580 | 1,584 | -97 | -5.8% | 322,400 |
| 2022/12/30 | 1,691 | 1,703 | 1,680 | 1,681 | +3 | +0.2% | 175,500 |
| 2022/12/29 | 1,679 | 1,688 | 1,652 | 1,678 | +1 | +0.1% | 238,000 |
| 2022/12/28 | 1,655 | 1,688 | 1,636 | 1,677 | +9 | +0.5% | 278,700 |
601～
650
件表示中 / 7022件
類似銘柄と比較する
現在ご覧いただいている「ＪＣＲファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＪＣＲファーマ | 62,900円 | +14.3% | - | 3.18% | 25.57倍 | 1.63倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ネクセラファーマ | 95,000円 | +20.3% | - | 0.00% | 168.44倍 | 1.31倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ハートシード | 364,000円 | +246.7% | - | 0.00% | 774.47倍 | 11.02倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
| あすかＨＤ | 254,000円 | +16.9% | +33.2% | 2.17% | 13.87倍 | 1.10倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| ヘリオス | 57,300円 | +150.0% | - | 0.00% | - | 52.71倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
市場注目の銘柄
チャート関連のコラム
